SynthesisScientific reports2024
Systematic review and meta-analysis of human bocavirus as food safety risk in shellfish.
Synthesis in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tracking the occurrence and fate of human bocavirus 2 in municipal wastewater from a small city.Molecular biology reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human bocavirus (HBoV) is an emerging pathogen causing gastroenteritis/respiratory tract infection. Shellfish has been implicated in foodborne HBoV dissemination. The present investigation aimed at synthesising shellfish-associated HBoV data. Shellfish-HBoV data were mined from public repositories using topic-specific algorithm. A total of 30 data sources was identified of which 5 were synthesised. The average HBoV positivity and sample-size was 12 ± 9.2 and 134.2 ± 113.6, respectively. HBoV was studied in mollusc with 3.7-83.3% crude prevalence. The pooled HBoV prevalence in shellfish was 9.2% (7.2-11.8; 5 studies) and 12.9% (1.8-53.9; 5 studies) in common-effects and random-effects model respectively, with 0.12-94.89% prediction interval (PI). Sensitivity analysis yielded 8.7% (6.7-11.2; PI = 1.99-29.48%) prevalence. HBoV1 and HBoV2 pooled prevalence in shellfish was 7.91% (1.61-31.09; 3 studies) and 12.52% (0.01-99.60; 3 studies), respectively. HBoV3 prevalence was reported in one single study as 6.96% (4.41-10.35). In conclusion, the present study revealed high HBoV prevalence in shellfish, signifying the need to characterise HBoV and subtypes circulating in non-mollusc shellfish. Furthermore, there is an urgent need to mitigate the food safety risk that may result from HBoV contaminated shellfish since shellfish-borne HBoV is not routinely assessed and might be underestimated at present.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.